BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11044465)

  • 1. p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts.
    Takahashi K; Kobayashi T; Kanayama N
    Mol Hum Reprod; 2000 Nov; 6(11):1019-25. PubMed ID: 11044465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo.
    Gómez Lahoz E; Liegeois NJ; Zhang P; Engelman JA; Horner J; Silverman A; Burde R; Roussel MF; Sherr CJ; Elledge SJ; DePinho RA
    Mol Cell Biol; 1999 Jan; 19(1):353-63. PubMed ID: 9858559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
    Matsuoka S; Edwards MC; Bai C; Parker S; Zhang P; Baldini A; Harper JW; Elledge SJ
    Genes Dev; 1995 Mar; 9(6):650-62. PubMed ID: 7729684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.
    Yan Y; Frisén J; Lee MH; Massagué J; Barbacid M
    Genes Dev; 1997 Apr; 11(8):973-83. PubMed ID: 9136926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer.
    Liang B; Wang S; Yang X; Ye Y; Yu Y; Cui Z
    Chin Med J (Engl); 2003 Jan; 116(1):20-3. PubMed ID: 12667381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
    Joaquin M; Watson RJ
    J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role for the 310 helix region of p57(Kip2) in cyclin-dependent kinase 2 inhibition and growth suppression.
    Hashimoto Y; Kohri K; Kaneko Y; Morisaki H; Kato T; Ikeda K; Nakanishi M
    J Biol Chem; 1998 Jun; 273(26):16544-50. PubMed ID: 9632724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased IGF-II protein affects p57kip2 expression in vivo and in vitro: implications for Beckwith-Wiedemann syndrome.
    Grandjean V; Smith J; Schofield PN; Ferguson-Smith AC
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5279-84. PubMed ID: 10779549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodic expression of the cyclin-dependent kinase inhibitor p57(Kip2) in trophoblast giant cells defines a G2-like gap phase of the endocycle.
    Hattori N; Davies TC; Anson-Cartwright L; Cross JC
    Mol Biol Cell; 2000 Mar; 11(3):1037-45. PubMed ID: 10712518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts.
    Reynaud EG; Pelpel K; Guillier M; Leibovitch MP; Leibovitch SA
    Mol Cell Biol; 1999 Nov; 19(11):7621-9. PubMed ID: 10523650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour.
    Taniguchi T; Okamoto K; Reeve AE
    Oncogene; 1997 Mar; 14(10):1201-6. PubMed ID: 9121769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of p57(KIP2) gene mutation in Beckwith-Wiedemann syndrome.
    Gaston V; Le Bouc Y; Soupre V; Vazquez MP; Gicquel C
    Horm Res; 2000; 54(1):1-5. PubMed ID: 11182628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The developmental expression of the CDK inhibitor p57(kip2) (Cdkn1c) in the early mouse placenta.
    Saunders AC; McGonnigal B; Uzun A; Padbury J
    Mol Reprod Dev; 2016 May; 83(5):405-12. PubMed ID: 26988311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic temporal and spatial regulation of the cdk inhibitor p57(kip2) during embryo morphogenesis.
    Westbury J; Watkins M; Ferguson-Smith AC; Smith J
    Mech Dev; 2001 Nov; 109(1):83-9. PubMed ID: 11677056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development.
    Zhang P; Wong C; DePinho RA; Harper JW; Elledge SJ
    Genes Dev; 1998 Oct; 12(20):3162-7. PubMed ID: 9784491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p57(Kip2) regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina.
    Dyer MA; Cepko CL
    Development; 2000 Aug; 127(16):3593-605. PubMed ID: 10903183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of MyoD by direct binding to p57(Kip2).
    Reynaud EG; Leibovitch MP; Tintignac LA; Pelpel K; Guillier M; Leibovitch SA
    J Biol Chem; 2000 Jun; 275(25):18767-76. PubMed ID: 10764802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal-induced ubiquitination of p57(Kip2) is independent of the C-terminal consensus Cdk phosphorylation site.
    Leibovitch MP; Kannengiesser C; Leibovitch SA
    FEBS Lett; 2003 May; 543(1-3):125-8. PubMed ID: 12753918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distant cis-elements regulate imprinted expression of the mouse p57( Kip2) (Cdkn1c) gene: implications for the human disorder, Beckwith--Wiedemann syndrome.
    John RM; Ainscough JF; Barton SC; Surani MA
    Hum Mol Genet; 2001 Jul; 10(15):1601-9. PubMed ID: 11468278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human p57(KIP2) transgene is not activated by passage through the maternal mouse germline.
    John RM; Hodges M; Little P; Barton SC; Surani MA
    Hum Mol Genet; 1999 Nov; 8(12):2211-9. PubMed ID: 10545601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.